NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma

Invasive mucinous lung adenocarcinoma (IMA) is a rare subtype of lung adenocarcinoma with no effective treatment option in advanced disease. KRAS mutations occur in 28–87% of the cases. NRG1 fusions were recently discovered in KRAS‐negative IMA cases and otherwise negative for known driver oncogenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Duruisseaux, Michaël, McLeer‐Florin, Anne, Antoine, Martine, Alavizadeh, Sanaz, Poulot, Virginie, Lacave, Roger, Rabbe, Nathalie, Cadranel, Jacques, Wislez, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224837/
https://www.ncbi.nlm.nih.gov/pubmed/27770508
http://dx.doi.org/10.1002/cam4.838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224837/
https://www.ncbi.nlm.nih.gov/pubmed/27770508
http://dx.doi.org/10.1002/cam4.838

Ejemplares similares